LABOCANNA S.A. ZY-10 (F:9Y2) — Market Cap & Net Worth
Market Cap & Net Worth: LABOCANNA S.A. ZY-10 (9Y2)
LABOCANNA S.A. ZY-10 (F:9Y2) has a market capitalization of $818.21K (€699.86K) as of August 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #30685 globally and #2693 in its home market, demonstrating a -2.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LABOCANNA S.A. ZY-10's stock price €0.04 by its total outstanding shares 21197160 (21.20 Million). See LABOCANNA S.A. ZY-10 (9Y2) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
LABOCANNA S.A. ZY-10 Market Cap History: 2021 to 2026
LABOCANNA S.A. ZY-10's market capitalization history from 2021 to 2026. Data shows change from $7.78 Million to $921.88K (-39.55% CAGR).
LABOCANNA S.A. ZY-10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LABOCANNA S.A. ZY-10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
66.08x
LABOCANNA S.A. ZY-10's market cap is 66.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $2.30 Million | $2.93K | -$1.19 Million | 785.93x | N/A |
| 2023 | $1.84 Million | $16.52K | -$598.72K | 111.31x | N/A |
| 2024 | $1.34 Million | $2.50K | -$606.80K | 537.34x | N/A |
| 2025 | $867.36K | $13.13K | -$597.87K | 66.08x | N/A |
Competitor Companies of 9Y2 by Market Capitalization
Companies near LABOCANNA S.A. ZY-10 in the global market cap rankings as of August 4, 2026.
Key companies related to LABOCANNA S.A. ZY-10 by market ranking:
- Cintas Corporation (NASDAQ:CTAS): Ranked #384 globally with a market cap of $71.97 Billion USD.
- Thomson Reuters Corp (TO:TRI): Ranked #611 globally with a market cap of $44.27 Billion USD ( CA$61.20 Billion CAD).
- Copart Inc (NASDAQ:CPRT): Ranked #942 globally with a market cap of $28.27 Billion USD.
- RB Global (TO:RBA): Ranked #1235 globally with a market cap of $20.72 Billion USD ( CA$28.65 Billion CAD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #384 | Cintas Corporation | NASDAQ:CTAS | $71.97 Billion | $204.01 |
| #611 | Thomson Reuters Corp | TO:TRI | $44.27 Billion | CA$137.52 |
| #942 | Copart Inc | NASDAQ:CPRT | $28.27 Billion | $29.35 |
| #1235 | RB Global | TO:RBA | $20.72 Billion | CA$153.76 |
LABOCANNA S.A. ZY-10 Historical Marketcap From 2021 to 2026
Between 2021 and today, LABOCANNA S.A. ZY-10's market cap moved from $7.78 Million to $ 921.88K, with a yearly change of -39.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €921.88K | +6.29% |
| 2025 | €867.36K | -35.42% |
| 2024 | €1.34 Million | -26.95% |
| 2023 | €1.84 Million | -20.22% |
| 2022 | €2.30 Million | -70.38% |
| 2021 | €7.78 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of LABOCANNA S.A. ZY-10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $818.21K USD |
| MoneyControl | $818.21K USD |
| MarketWatch | $818.21K USD |
| marketcap.company | $818.21K USD |
| Reuters | $818.21K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its name to Labocanna S.A. in January 2021. Labocanna S.A. was incorporat… Read more